Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen

Transfusion Medicine

Volumn 17, Issue 5, 2007, Pages 399-403

  Chaffe, B ^a   Ford, J ^b   Bills, V ^b  

^a WILLIAM HARVEY HOSPITAL   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

Antenatal prophylaxis; Anti D immunoglobulin; Compliance; Haemolytic disease of the newborn; RhD sensitization; Two dose regimen

Indexed keywords

RHESUS D ANTIBODY;

ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN HEMOLYTIC DISEASE; PATIENT COMPLIANCE; PREGNANCY; PRENATAL PERIOD; PROPHYLAXIS; SENSITIZATION; UNITED KINGDOM;

DRUG ADMINISTRATION SCHEDULE; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; MEDICAL AUDIT; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, THIRD; PRENATAL CARE; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 34848823483     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2007.00777.x     Document Type: Article

References (12)

1. Audit Commission (2005) Managing the financial implications of NICE guidance. Health National report. URL http://www.audit-commission.gov.uk/ reports/ last accessed on 12 June 2006 2006) Rh-immunoglobulin: Rh prophylaxis. Best Practice & Research Clinical Haematology, 19, 27 34.
2. Duguid, J.K.M 1997) Antenatal serological testing and prevention of haemolytic disease of the newborn. Journal of Clinical Pathology, 50, 193 196.
3. Huchet, J., Dallemagne, S., Huchet, C., Brossard, Y., Larsen, M. Parnet-Mathieu, F 1987) Application ante-partum du traitement preventif d'immunisation rhesus D chez les femmes rhesus negatif. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 16, 101 111.
4. Letsky, E.A. de Silva, M 1994) Preventing Rh immunisation. BMJ, 309, 213 214.
5. MacKenzie, I 2004) Antenatal anti-D prophylaxis: one dose or two? British Journal of Midwifery, 12, 1 6.
6. MacKenzie, I.Z., Bowell, P., Gregory, H., Pratt, G., Guest, C. Entwistle, C.C 1999) Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. British Journal of Obstetrics and Gynaecology, 106, 492 497.
7. MacKenzie, I.Z., Findlay, J. Roseman, F 2006) Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitizations: observations over 14 years. BJOG: An International Journal of Obstetrics and Gynaecology, 113, 839 843.
8. Mayne, S., Parker, J.H., Harden, T.A., Dodds, S.D. Beale, J.A 1997) Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme. BMJ, 315, 1588.
9. National Collaborating Centre for Women's and Children's Health 2003) Antenatal Care: Routine Care for the Healthy Pregnant Woman. RCOG Press, London (http://www.rcog.org.uk/)
10. National Institute for Clinical Excellence (NICE) 2002). Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women. URL http://www.nice.org.uk last accessed on 12 June 2006 Qureshi, H 2006) Guidelines for the use of prophylactic anti-D immunoglobulin. British Committee for Standards in Haematology. URL http://www.bcshguidelines.com last accessed on 12 June 2006 Wright, J. (2004) What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ, 329 (7473 999.
11. Thornton, J.G., Page, C., Foote, G., Arthur, G.R., Tovey, L.A.D. Scott, J.S 1989) Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin. BMJ, 298, 1671 1673.
12. Tovey, L.A., Townley, A., Stevenson B.J. Taverner, J 1983) The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet, 2, 244 246.